Blog

Talking about prostate cancer research and initiatives with MLA Richard Starke

MLA Dr. Richard Starke Toured APCaRI Labs

The APCaRI laboratory in the Department of Oncology at the University of Alberta hosted an early morning visit on October 11 by Dr. Richard Starke, MLA for Vermilion-Lloydminster @RichardStarke. Dr. John Lewis led the tour of the facility and discussed the work being done by APCaRI members on using the in vivo chick embryo imaging technique to follow tumour motility through the vasculature, screening for metastasis-gene targets in human cancers to develop metastasis-blocking therapeutics, and the design of Nanostics’ prostate cancer diagnostic blood tests platform; ClarityDx Prostate. Later that day Richard Starke tweeted about his visit describing it as an incredible tour of @UAlberta research facilities!
Along with Dr.’s Starke and Lewis (from left to right in feature photo above) were technicians Mike Wong and Diana Pham, Nanostics COO Catalina Vasquez, technician Renjith Pillai and our Program manager Rume Djebah.

Stay Informed

To stay up to date on all the latest news and publications, subscribe to our newsletter!

Recent Posts

15th Annual Personalized Medicine Conference Posted on Nov 9 19 at 5:14pm
Evaluating the measurement properties of EPIC-26 Posted on Nov 6 19 at 12:19pm
APCaRI 2019 Fall Symposium Posted on Oct 22 19 at 12:28pm

15th Annual Personalized Medicine Conference

Conference speakers will be focused on science, business, and policy issues facing personalized medicine scientists as they augment their research with AI and advanced data analytics. Digital health applications are expanding. Personalized medicine is evolving. This new paradigm will empower physicians and patients with a data-rich, expanded set of ‘omic and microbiome biological characteristics.
What are the predicted results of this evolution? Access to increasingly impactful therapies for patients and their healthcare teams.
Rume will be attending this conference to listen to experts in the field of Personalized medicine and learn how they are approaching these issues and turning them into opportunities for APCaRI.

- Unknown